Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?

被引:38
作者
Diamanti-Kandarakis, Evanthia [1 ]
Livadas, Sarantis [1 ]
Kandarakis, Stylianos A. [1 ]
Margeli, Alexandra [2 ]
Papassotiriou, Ioannis [2 ]
机构
[1] Univ Athens, Endocrine Sect, Dept Med 1, Sch Med,Laiko Gen Hosp, Athens 11527, Greece
[2] Aghia Sophia Childrens Hosp, Dept Clin Biochem, Athens 11527, Greece
关键词
D O I
10.1530/EJE-07-0822
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) have been considered as important mediators of vascular remodeling and plaque instability. The formation of a complex with NGAL and MMP-9 is crucial for atherotic plaque erosion and thrombus formation. In women with polycystic ovary syndrome (PCOS), the incidence of cardiovascular clinical events is not increased, despite the fact that they display a wide spectrum of risk factors. Since the instability of atherosclerotic plaque is a key factor in the clinical manifestations of cardiovascular disease, molecules challenging the plaque stability should be investigated. Aim: To determine serum levels of NGAL and MMP-9/NGAL complex in women with PCOS. Subjects and methods: PCOS subjects (40) were compared with those (40) matched for age and body mass index (BMI) controls. In each subject, fasting levels of glucose, insulin, gonadotropins, estradiol, androgens, C-reactive protein, NGAL, and MMP-9/NGAL were determined. Results: NGAL and MMP-9/NGAL complex levels were significantly lower in the PCOS group compared with controls (30.4 +/- 24.3 vs 70.7 +/- 37.9 mu g/l P < 0.0001) and (31.5 +/- 26.6 vs 115.1 +/- 66.9 mu g/l, P < 0.0001) respectively. When patients and controls were stratified according to BMI, it was shown that NGAL and MMP-9/NGAL levels were significantly lower in lean (P < 0.0002 and P < 0.0001 respectively) and overweight (P < 0.0004 and P < 0.002 respectively) PCOS subjects compared with controls. Conclusions: These findings indicate that NGAL and MMP-9/NGAL complex, two molecules that activate atherotic plaque erosion, is in lower concentrations in PCOS subjects. The role of NGAL and MMP-9/NGAL complex needs to be further investigated, since suppression of these atheromatous molecules might have a protective role in women with PCOS.
引用
收藏
页码:525 / 531
页数:7
相关论文
共 30 条
[1]   Endogenous androgens and carotid intimal-medial thickness in women [J].
Bernini, GP ;
Sgro', M ;
Moretti, A ;
Argenio, GF ;
Barlascini, CO ;
Cristofani, R ;
Salvetti, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :2008-2012
[2]   Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-κB [J].
Bu, De-xiu ;
Hemdahl, Anne-Louise ;
Gabrielsen, Anders ;
Fuxe, Jonas ;
Zhu, Chaoyong ;
Eriksson, Per ;
Yan, Zhong-qun .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (06) :2245-2253
[3]   Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance [J].
Coviello, AD ;
Legro, RS ;
Dunaif, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) :492-497
[4]   Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives [J].
Cussons, AJ ;
Stuckey, BGA ;
Watts, GF .
ATHEROSCLEROSIS, 2006, 185 (02) :227-239
[5]   A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile [J].
Diamanti-Kandarakis, E ;
Kouli, CR ;
Bergiele, AT ;
Filandra, FA ;
Tsianateli, TC ;
Spina, GG ;
Zapanti, ED ;
Bartzis, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4006-4011
[6]   Metformin administration improves endothelial function in women with polycystic ovary syndrome [J].
Diamanti-Kandarakis, E ;
Alexandraki, K ;
Protogerou, A ;
Piperi, C ;
Papamichael, C ;
Aessopos, A ;
Lekakis, J ;
Mavrikakis, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (05) :749-756
[7]   Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin [J].
Diamanti-Kandarakis, Evanthia ;
Paterakis, Thomas ;
Alexandraki, Krystallenia ;
Piperi, Christina ;
Aessopos, Athanasios ;
Katsikis, Ilias ;
Katsilambros, Nikolaos ;
Kreatsas, George ;
Panidis, Dimitrios .
HUMAN REPRODUCTION, 2006, 21 (06) :1426-1431
[8]   Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis [J].
Dunaif, A .
ENDOCRINE REVIEWS, 1997, 18 (06) :774-800
[9]  
Dunaif A, 1992, CURRENT ISSUES ENDOC
[10]   Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Liljenquist, DR ;
Kasza, K ;
Azziz, R ;
Legro, RS ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :48-53